Ciprofloxacin And Dexamethasone Suspension/ Drops
Product Images NDC 68071-3977

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin And Dexamethasone (NDC 68071-3977). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3977 7)

Ciprofloxacin and dexamethasone 0.3%/0.1% otic suspension label from NuCare Pharmaceuticals, Inc. The 7.5 mL bottle contains ciprofloxacin 3 mg/mL and dexamethasone 1 mg/mL. The label includes dosage instructions, storage temperature of 68-77°F, NDC 68071-3977-7, and safety warnings such as keeping out of reach of children.*

FDA Label Image

Spl-ciprofoxacin-structure (Spl Ciprofloxacin Structure)

Chemical structure of ciprofloxacin hydrochloride monohydrate, showing a fluoroquinolone core with a cyclopropyl group and carboxylic acid functional group, consistent with the ciprofloxacin component of the product Ciprofloxacin and dexamethasone suspension/drops.*

FDA Label Image

Spl-dexamethasone-structure (Spl Dexamethasone Structure)

Chemical structure diagram of dexamethasone, one of the active ingredients in the Ciprofloxacin and dexamethasone otic suspension/drops by NuCare Pharmaceutical, Inc.*

FDA Label Image

Spl-figure-a (Spl Figure A)

An instructional illustration showing a hand held under a running faucet with water and soap lather, demonstrating proper handwashing technique.*

FDA Label Image

Spl-figure-b (Spl Figure B)

An instructional illustration showing hands holding a small bottle, likely demonstrating how to hold or administer Ciprofloxacin and dexamethasone auricular suspension/drops. The bottle has a dropper cap for dispensing the medication.*

FDA Label Image

Spl-figure-c (Spl Figure C)

An instructional black-and-white line drawing illustrating the proper administration of ear drops. The image shows a person lying on their side with one ear exposed upward, and droplets being instilled into the ear canal. This diagram is typically used for guiding auricular (otic) suspension or drops application.*

FDA Label Image

Spl-figure-d (Spl Figure D)

An instructional illustration showing a hand holding a dropper bottle, dispensing liquid drops into a person's ear. The image demonstrates correct administration of ear drops.*

FDA Label Image

Spl-figure-e (Spl Figure E)

An instructional illustration showing finger manipulation of the ear near the tragus. The sequence depicts pressing down, releasing, and repeating the motion five times, likely to aid in administration of an otic suspension or drops.*

FDA Label Image

Spl-figure-f (Spl Figure F)

An instructional diagram illustrating ear drop administration. It shows hand positioning with arrows indicating to pull the ear upward and backward to properly instill the drops into the ear canal.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.